For the quarter ending 2026-03-31, PCRX has $1,208,534K in assets. $554,641K in debts. $144,306K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 144,306 | 158,545 | 147,589 | 300,484 |
| Short-term available-for-sale investments | 57,874 | 79,879 | 98,745 | 145,380 |
| Accounts receivable, net | 125,635 | 124,069 | 115,268 | 114,367 |
| Inventories, net | 150,370 | 152,863 | 157,680 | 148,163 |
| Prepaid expenses and other current assets | 36,776 | 32,618 | 43,469 | 37,219 |
| Total current assets | 514,961 | 547,974 | 562,751 | 745,613 |
| Fixed assets, net | 136,281 | 140,690 | 147,388 | 155,178 |
| Right-of-use assets, net | 39,409 | 41,777 | 44,266 | 46,528 |
| Goodwill | 19,773 | 20,214 | 20,317 | 20,300 |
| Intangible assets, net | 319,494 | - | - | - |
| Gross carrying value | 33,733 | - | - | - |
| Intangible assets, net | 353,227 | 368,100 | 382,396 | 422,563 |
| Deferred tax assets | 122,115 | 123,854 | 120,188 | 128,270 |
| Investments and other assets | 22,768 | 22,308 | 20,271 | 18,810 |
| Total assets | 1,208,534 | 1,264,917 | 1,297,577 | 1,537,262 |
| Accounts payable | 14,012 | 15,150 | 17,687 | 30,124 |
| Current portion of convertible senior notes, net | - | - | - | 202,397 |
| Accrued expenses | 84,957 | 95,601 | 79,643 | 71,023 |
| Lease liabilities | 9,818 | 9,839 | 9,748 | 9,620 |
| Current portion of long-term debt, net | - | 0 | 0 | - |
| Total current liabilities | 108,787 | 120,590 | 107,078 | 313,164 |
| Long-term debt, net | 367,656 | 372,189 | 376,721 | - |
| Convertible senior notes, net | - | - | - | 280,267 |
| Lease liabilities | 33,705 | 36,176 | 38,839 | 41,291 |
| Contingent consideration | 15,789 | 18,066 | 17,834 | 17,209 |
| Long-term debt, net | - | - | - | 97,828 |
| Deferred tax liabilities | 4,093 | 4,213 | 4,587 | 4,583 |
| Other liabilities | 24,611 | 20,572 | 25,304 | 25,153 |
| Total liabilities | 554,641 | 571,806 | 570,363 | 779,495 |
| Common stock, par value 0.001 250,000,000 shares authorized 48,328,201 shares issued and 39,309,610 shares outstanding at march31, 2026 and 47,890,777 shares issued and 41,116,739 shares outstanding at december31, 2025 | 48 | 48 | 48 | 48 |
| Treasury stock, at cost, inclusive of excise tax and broker fees, 9,018,591 and 6,774,038 shares at march31, 2026 and december31, 2025, respectively | 227,013 | 176,565 | 125,543 | 75,515 |
| Additional paid-in capital | 1,073,809 | 1,064,623 | 1,049,545 | 1,035,563 |
| Accumulated deficit | -196,406 | -199,322 | -200,959 | -206,391 |
| Accumulated other comprehensive income | 3,455 | 4,327 | 4,123 | 4,062 |
| Total stockholders equity | 653,893 | 693,111 | 727,214 | 757,767 |
| Total liabilities and stockholders equity | 1,208,534 | 1,264,917 | 1,297,577 | 1,537,262 |
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)